Home Biotechnology Live Biotherapeutic Products And Microbiome CDMO Market Size, Top Share to 2033

Live Biotherapeutic Products And Microbiome CDMO Market Size & Outlook, 2025-2033

Live Biotherapeutic Products And Microbiome CDMO Market Size, Share & Trends Analysis Report By Component (Solution, Services), By Type (Bacterial LBPs, Viral LBPs, Fungal LBPs, Others), By Application (Gastrointestinal Disorders, Oncology, Neurological Disorders, Infectious Diseases, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI57361DR
Last Updated : Jun, 2025
Pages : 110
Author : Dhanashri Bhapakar
Format : PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Live Biotherapeutic Products And Microbiome CDMO Market Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Solution
        1. By Value
      3. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Bacterial LBPs
        1. By Value
      3. Viral LBPs
        1. By Value
      4. Fungal LBPs
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gastrointestinal Disorders
        1. By Value
      3. Oncology
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Infectious Diseases
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Solution
        1. By Value
      3. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Bacterial LBPs
        1. By Value
      3. Viral LBPs
        1. By Value
      4. Fungal LBPs
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gastrointestinal Disorders
        1. By Value
      3. Oncology
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Infectious Diseases
        1. By Value
      6. Others
        1. By Value
    5. U.S.
      1. By Component
        1. Introduction
          1. Component By Value
        2. Solution
          1. By Value
        3. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Bacterial LBPs
          1. By Value
        3. Viral LBPs
          1. By Value
        4. Fungal LBPs
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gastrointestinal Disorders
          1. By Value
        3. Oncology
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Infectious Diseases
          1. By Value
        6. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Solution
        1. By Value
      3. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Bacterial LBPs
        1. By Value
      3. Viral LBPs
        1. By Value
      4. Fungal LBPs
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gastrointestinal Disorders
        1. By Value
      3. Oncology
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Infectious Diseases
        1. By Value
      6. Others
        1. By Value
    5. U.K.
      1. By Component
        1. Introduction
          1. Component By Value
        2. Solution
          1. By Value
        3. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Bacterial LBPs
          1. By Value
        3. Viral LBPs
          1. By Value
        4. Fungal LBPs
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gastrointestinal Disorders
          1. By Value
        3. Oncology
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Infectious Diseases
          1. By Value
        6. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Solution
        1. By Value
      3. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Bacterial LBPs
        1. By Value
      3. Viral LBPs
        1. By Value
      4. Fungal LBPs
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gastrointestinal Disorders
        1. By Value
      3. Oncology
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Infectious Diseases
        1. By Value
      6. Others
        1. By Value
    5. China
      1. By Component
        1. Introduction
          1. Component By Value
        2. Solution
          1. By Value
        3. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Bacterial LBPs
          1. By Value
        3. Viral LBPs
          1. By Value
        4. Fungal LBPs
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gastrointestinal Disorders
          1. By Value
        3. Oncology
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Infectious Diseases
          1. By Value
        6. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Solution
        1. By Value
      3. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Bacterial LBPs
        1. By Value
      3. Viral LBPs
        1. By Value
      4. Fungal LBPs
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gastrointestinal Disorders
        1. By Value
      3. Oncology
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Infectious Diseases
        1. By Value
      6. Others
        1. By Value
    5. UAE
      1. By Component
        1. Introduction
          1. Component By Value
        2. Solution
          1. By Value
        3. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Bacterial LBPs
          1. By Value
        3. Viral LBPs
          1. By Value
        4. Fungal LBPs
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gastrointestinal Disorders
          1. By Value
        3. Oncology
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Infectious Diseases
          1. By Value
        6. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Component
      1. Introduction
        1. Component By Value
      2. Solution
        1. By Value
      3. Services
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Bacterial LBPs
        1. By Value
      3. Viral LBPs
        1. By Value
      4. Fungal LBPs
        1. By Value
      5. Others
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Gastrointestinal Disorders
        1. By Value
      3. Oncology
        1. By Value
      4. Neurological Disorders
        1. By Value
      5. Infectious Diseases
        1. By Value
      6. Others
        1. By Value
    5. Brazil
      1. By Component
        1. Introduction
          1. Component By Value
        2. Solution
          1. By Value
        3. Services
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Bacterial LBPs
          1. By Value
        3. Viral LBPs
          1. By Value
        4. Fungal LBPs
          1. By Value
        5. Others
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Gastrointestinal Disorders
          1. By Value
        3. Oncology
          1. By Value
        4. Neurological Disorders
          1. By Value
        5. Infectious Diseases
          1. By Value
        6. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Live Biotherapeutic Products And Microbiome CDMO Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Lonza Group
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. WuXi Biologics
    3. Thermo Fisher Scientific
    4. Catalent
    5. Bacthera
    6. Seres Therapeutics
    7. Ferring Pharmaceuticals
    8. Exeliom Biosciences
    9. 4D Pharma
    10. Finch Therapeutics
    11. Vedanta Biosciences
    12. Hansen Holding
    13. Recipharm
    14. Evonik Industries
    15. Biocon
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on :

WhatsApp
Chat with us on WhatsApp
Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.